ScholarIQanswers from OpenAlex & ORCID
Terry J. Fry
ResearcherPublications, citations & collaboration network
Terry J. Fry is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Terry J. Fry have?
ScholarIQindexed works
Terry J. Fry has 364 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Terry J. Fry have?
ScholarIQcitation count
Terry J. Fry has 23,504 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Terry J. Fry?
ScholarIQh-index
Terry J. Fry has an h-index of 62 in OpenAlex.
What is the i10-index of Terry J. Fry?
ScholarIQi10-index
Terry J. Fry has an i10-index of 134 in OpenAlex.
What is the ORCID of Terry J. Fry?
ScholarIQorcid
The ORCID for Terry J. Fry is on the source record.
What is the OpenAlex record for Terry J. Fry?
ScholarIQopenalex
The OpenAlex for Terry J. Fry is on the source record.
What are the most-cited papers on Terry J. Fry?
ScholarIQmost cited works
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, Yongzhi Cui, Cindy Delbrook, Steven A. Feldman, Terry J. Fry, Rimas J. Orentas, Marianna Sabatino, Nirali N. Shah, Seth M. Steinberg, D. Stroncek, Nick Tschernia, Constance M. Yuan, Hua Zhang, Ling Zhang, Steven A. Rosenberg, Alan S. Wayne, Crystal L. Mackall
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry, Nirali N. Shah, Rimas J. Orentas, Maryalice Stetler‐Stevenson, Constance M. Yuan, Sneha Ramakrishna, Pamela L. Wolters, Staci Martin, Cindy Delbrook, Bonnie Yates, Haneen Shalabi, Thomas J. Fountaine, Jack F. Shern, Robbie G. Majzner, David F. Stroncek, Marianna Sabatino, Yang Feng, Dimiter S. Dimitrov, Ling Zhang, Sang M. Nguyen, Haiying Qin, Boro Dropulić, Daniel W Lee, Crystal L. Mackall
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N. Shah, Steven L. Highfill, Haneen Shalabi, Bonnie Yates, Jianjian Jin, Pamela L. Wolters, Amanda K. Ombrello, Seth M. Steinberg, Staci Martin, Cindy Delbrook, Leah Hoffman, Lauren Little, Anusha Ponduri, Haiying Qin, Haris Qureshi, Alina Dulau‐Florea, Dalia Salem, Hao‐Wei Wang, Constance M. Yuan, Maryalice Stetler‐Stevenson, Sandhya R. Panch, Minh Tran, Crystal L. Mackall, David F. Stroncek, Terry J. Fry
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy Delbrook, Maryalice Stetler‐Stevenson, Terry J. Fry, David F. Stroncek, Crystal L. Mackall
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L. Wolters, Seth M. Steinberg, John A. Ligon, Sara Silbert, Kniya DéDé, Mehdi Benzaoui, Sophia Goldberg, Sooraj Achar, Dina Schneider, Shilpa Shahani, Lauren Little, Toni Foley, John C. Molina, Sandhya R. Panch, Crystal L. Mackall, Daniel W. Lee, Christopher D. Chien, Marie Pouzolles, Mark A. Ahlman, Constance M. Yuan, Hao‐Wei Wang, Yanyu Wang, Jon R. Inglefield, Mary Anne Toledo‐Tamula, Staci Martin, Steven L. Highfill, Grégoire Altan‐Bonnet, David Stroncek, Terry J. Fry, Naomi Taylor, Nirali N. Shah